GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Concord Biotech Ltd

Concord Biotech Ltd Fixes Record Date for 1:1 Bonus Share Issuance

BONUS ▲ Positive Development LOW RISK
📅 Filed on BSE: 27 Oct 2026, 07:27 PM IST  ·  BSE ID: 7549414a-a2c4-42b2-adb6-916b8e26c1e8
View Original BSE Filing (PDF)
💡
In Simple Terms
Concord Biotech is giving shareholders one extra share for every share they already own, with November 4th as the cut-off date.
🤖 AI Summary
  • Concord Biotech Limited sets November 04, 2026, as record date for 1:1 bonus share issuance.
  • Board of Directors approved bonus shares in ratio of one for one existing equity share.
  • Deemed date of allotment for bonus shares is November 05, 2026.
  • This is a corporate action to reward existing shareholders.
  • The decision follows a Board Meeting held on October 27, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Bonus Ratio
1:1
Record Date
November 04, 2026
Deemed Allotment Date
November 05, 2026
🏢 How This Affects the Company
💰
Financial Impact
Issuance of bonus shares increases the number of outstanding equity shares without impacting the company's reserves or net worth immediately. This will dilute Earnings Per Share (EPS) if profits remain unchanged.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders as bonus shares will be automatically credited to their accounts.
👤
Who Is Affected
All equity shareholders holding shares as of November 04, 2026, will be entitled to receive bonus equity shares in the ratio of 1:1.
🔍
Management Signal
The bonus issue signals management's intent to reward shareholders and signal confidence in the company's future performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of statutory and regulatory approvals for bonus share issuance.
Update on the actual credit of bonus shares to eligible demat accounts.
Company's next quarterly results to observe impact on EPS.
LOW RISK The filing is a standard corporate action for bonus share issuance and carries minimal inherent risk.
💡 Investor Takeaway
Concord Biotech will issue bonus equity shares in a 1:1 ratio. The record date is November 04, 2026, with allotment on November 05, 2026.
❓ Frequently Asked Questions
What is the bonus share ratio for Concord Biotech Limited?
Concord Biotech Limited will issue bonus equity shares in the ratio of 1:1, meaning one new bonus share for every one existing fully paid-up share held.
What is the record date for Concord Biotech's bonus share issuance?
The record date fixed by the Board of Directors for determining entitlement to bonus equity shares is Wednesday, November 04, 2026.
When will the bonus shares be allotted by Concord Biotech Limited?
Thursday, November 05, 2026, shall be the deemed date of allotment for the bonus equity shares.
Do shareholders need to take any action for the bonus shares?
No action is required from shareholders as the bonus shares will be credited directly to their demat accounts based on the record date.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.